These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23166498)

  • 1. Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides.
    Arnold JJ; Sharma SD; Feng JY; Ray AS; Smidansky ED; Kireeva ML; Cho A; Perry J; Vela JE; Park Y; Xu Y; Tian Y; Babusis D; Barauskus O; Peterson BR; Gnatt A; Kashlev M; Zhong W; Cameron CE
    PLoS Pathog; 2012; 8(11):e1003030. PubMed ID: 23166498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs.
    Jin Z; Kinkade A; Behera I; Chaudhuri S; Tucker K; Dyatkina N; Rajwanshi VK; Wang G; Jekle A; Smith DB; Beigelman L; Symons JA; Deval J
    Antiviral Res; 2017 Jul; 143():151-161. PubMed ID: 28412183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
    Ehteshami M; Tao S; Ozturk T; Zhou L; Cho JH; Zhang H; Amiralaei S; Shelton JR; Lu X; Khalil A; Domaoal RA; Stanton RA; Suesserman JE; Lin B; Lee SS; Amblard F; Whitaker T; Coats SJ; Schinazi RF
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4659-69. PubMed ID: 27216050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase.
    Freedman H; Winter P; Tuszynski J; Tyrrell DL; Houghton M
    J Biol Chem; 2018 Jun; 293(25):9696-9705. PubMed ID: 29739852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
    Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
    J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus.
    Feng JY; Xu Y; Barauskas O; Perry JK; Ahmadyar S; Stepan G; Yu H; Babusis D; Park Y; McCutcheon K; Perron M; Schultz BE; Sakowicz R; Ray AS
    Antimicrob Agents Chemother; 2016 Feb; 60(2):806-17. PubMed ID: 26596942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase.
    Ehteshami M; Zhou L; Amiralaei S; Shelton JR; Cho JH; Zhang H; Li H; Lu X; Ozturk T; Stanton R; Amblard F; McBrayer TR; Coats SJ; Schinazi RF
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple
    Lu G; Bluemling GR; Mao S; Hager M; Gurale BP; Collop P; Kuiper D; Sana K; Painter GR; De La Rosa A; Kolykhalov AA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 2'-α-fluorine modified nucleoside phosphonates as potential inhibitors of HCV polymerase.
    Parrish JP; Lee SK; Boojamra CG; Hui H; Babusis D; Brown B; Shih IH; Feng JY; Ray AS; Mackman RL
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3354-7. PubMed ID: 23639543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Base-modified ribonucleosides as potential anti-hepatitis C virus agents.
    Ivanov AV; Smirnova OA; Golubeva NA; Ivanov MA; Tunitskaya VL; Shipitsyn AV; Alexandrova LA
    Nucleic Acids Symp Ser (Oxf); 2008; (52):619-20. PubMed ID: 18776532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agents.
    Yoo BN; Kim HO; Moon HR; Seol SK; Jang SK; Lee KM; Jeong LS
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4190-4. PubMed ID: 16781148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent highlights in the synthesis of anti-HCV ribonucleosides.
    Piperno A; Cordaro M; Scala A; Iannazzo D
    Curr Med Chem; 2014; 21(16):1843-60. PubMed ID: 24372207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
    Oh CH; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro.
    Migliaccio G; Tomassini JE; Carroll SS; Tomei L; Altamura S; Bhat B; Bartholomew L; Bosserman MR; Ceccacci A; Colwell LF; Cortese R; De Francesco R; Eldrup AB; Getty KL; Hou XS; LaFemina RL; Ludmerer SW; MacCoss M; McMasters DR; Stahlhut MW; Olsen DB; Hazuda DJ; Flores OA
    J Biol Chem; 2003 Dec; 278(49):49164-70. PubMed ID: 12966103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiviral evaluation of 2'-C-methyl analogues of 5-alkynyl- and 6-alkylfurano- and pyrrolo[2,3-d]pyrimidine ribonucleosides.
    Januszczyk P; Fogt J; Boryski J; Izawa K; Onishi T; Neyts J; De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):713-23. PubMed ID: 20183611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues.
    Brown NA
    Expert Opin Investig Drugs; 2009 Jun; 18(6):709-25. PubMed ID: 19426125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.
    Eldrup AB; Prhavc M; Brooks J; Bhat B; Prakash TP; Song Q; Bera S; Bhat N; Dande P; Cook PD; Bennett CF; Carroll SS; Ball RG; Bosserman M; Burlein C; Colwell LF; Fay JF; Flores OA; Getty K; LaFemina RL; Leone J; MacCoss M; McMasters DR; Tomassini JE; Von Langen D; Wolanski B; Olsen DB
    J Med Chem; 2004 Oct; 47(21):5284-97. PubMed ID: 15456273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-Target Effects of Drugs that Disrupt Human Mitochondrial DNA Maintenance.
    Young MJ
    Front Mol Biosci; 2017; 4():74. PubMed ID: 29214156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytostatic and antiviral 6-arylpurine ribonucleosides. Part 7: synthesis and evaluation of 6-substituted purine l-ribonucleosides.
    Hocek M; Silhár P; Shih IH; Mabery E; Mackman R
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5290-3. PubMed ID: 16905315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk.
    Fenaux M; Lin X; Yokokawa F; Sweeney Z; Saunders O; Xie L; Lim SP; Uteng M; Uehara K; Warne R; Gang W; Jones C; Yendluri S; Gu H; Mansfield K; Boisclair J; Heimbach T; Catoire A; Bracken K; Weaver M; Moser H; Zhong W
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7077-7085. PubMed ID: 27645237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.